Stonepine Capital Management, LLC Insider Trading $REPH Recro Pharma, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Stonepine Capital Management, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Stonepine Capital Management, LLC. Stonepine Capital Management, LLC is 10% Owner in VIVEVE MEDICAL, INC. ($VIVMF) and Director in VIVEVE MEDICAL, INC. ($VIVMF) and 10% Owner in Recro Pharma, Inc. ($REPH).
Stonepine Capital Management, LLC in Recro Pharma, Inc.
Trading Symbol: REPHIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Stonepine Capital Management, LLC: 10% Owner
Holdings: 1,976,310 shares
Current Value: $15,909,296
Latest Transaction: May 15 2017
$REPH Market Capitalization: $98.40M
$REPH Previous Close: $8.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Stonepine Capital Management, LLC in Recro Pharma, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 15 2017 | REPH | Recro Pharma, Inc. | Stonepine Capital Management, ... | 10% Owner | Sell | S | 7.40 | 73,930 | 547,112 | 1,902,380 | 2 M to 1.9 M (-3.74 %) |
May 15 2017 | REPH | Recro Pharma, Inc. | Stonepine Capital Management, ... | 10% Owner | Sell | S | 7.40 | 436,070 | 3,227,092 | 1,976,310 | 2.4 M to 2 M (-18.08 %) |
May 11 2017 | REPH | Recro Pharma, Inc. | Stonepine Capital Management, ... | 10% Owner | Sell | S | 7.96 | 1,304 | 10,386 | 2,412,380 | 2.4 M to 2.4 M (-0.05 %) |
May 11 2017 | REPH | Recro Pharma, Inc. | Stonepine Capital Management, ... | 10% Owner | Sell | S | 7.96 | 7,696 | 61,296 | 2,413,684 | 2.4 M to 2.4 M (-0.32 %) |
May 11 2017 | REPH | Recro Pharma, Inc. | Stonepine Capital Management, ... | 10% Owner | Sell | S | 7.77 | 1,088 | 8,457 | 2,421,380 | 2.4 M to 2.4 M (-0.04 %) |
May 11 2017 | REPH | Recro Pharma, Inc. | Stonepine Capital Management, ... | 10% Owner | Sell | S | 7.77 | 6,412 | 49,839 | 2,422,468 | 2.4 M to 2.4 M (-0.26 %) |
May 11 2017 | REPH | Recro Pharma, Inc. | Stonepine Capital Management, ... | 10% Owner | Sell | S | 7.64 | 33,070 | 252,493 | 2,428,880 | 2.5 M to 2.4 M (-1.34 %) |
May 11 2017 | REPH | Recro Pharma, Inc. | Stonepine Capital Management, ... | 10% Owner | Sell | S | 7.64 | 195,059 | 1,489,295 | 2,461,950 | 2.7 M to 2.5 M (-7.34 %) |
May 05 2017 | REPH | Recro Pharma, Inc. | Stonepine Capital Management, ... | 10% Owner | Sell | S | 7.69 | 29,160 | 224,270 | 2,657,009 | 2.7 M to 2.7 M (-1.09 %) |
May 05 2017 | REPH | Recro Pharma, Inc. | Stonepine Capital Management, ... | 10% Owner | Sell | S | 7.69 | 172,000 | 1,322,852 | 2,686,169 | 2.9 M to 2.7 M (-6.02 %) |
May 05 2017 | REPH | Recro Pharma, Inc. | Stonepine Capital Management, ... | 10% Owner | Sell | S | 7.79 | 2,340 | 18,235 | 2,858,169 | 2.9 M to 2.9 M (-0.08 %) |
May 05 2017 | REPH | Recro Pharma, Inc. | Stonepine Capital Management, ... | 10% Owner | Sell | S | 7.79 | 13,808 | 107,604 | 2,860,509 | 2.9 M to 2.9 M (-0.48 %) |
Page: 1